Abstract

LEIVA, Manuel H. et al. Clinical recommendations for the management of cancer patients during the COVID-19 pandemic. Rev. Fac. Med. Hum. [online]. 2020, vol.20, n.3, pp.464-470. ISSN 1814-5469.  http://dx.doi.org/10.25176/rfmh.v20i3.3032.

The disease by the new coronavirus strain (COVID-19) has been classified as a pandemic by the WHO. In Peru, a state of national emergency and compulsory social isolation had been declared since 15 March. Global health systems have been greatly impacted by COVID-19, which forced health systems, societies and medical associations to design prioritized intervention strategies to provide continuity of patient care in infected areas and COVID-19-free areas. A cancer patient is classified as vulnerable and represents a risk factor for complications due to COVID-19, such as admission to the intensive care unit, intubation, and early death due to infection due to COVID-19. This is how the Asociación de Médicos Ex Residentes de Oncología Médica (AMEROM), has endeavored to give recommendations adaptable to our health system, to continue with the prioritized care of cancer patients. Through the modified methodology of expert consensus, based on the literature, recommendations have been generated at different stages of the pandemic, reaching a final consensus of clinical recommendations for the management of cancer patients in the framework of the COVID-19 pandemic in Peru, to provide useful information to health professionals. This article indicates the processes by which agreements were reached to make recommendations and generate the order of priority adopted by AMEROM.

Keywords : SARS-CoV-2; Neoplasms (Source: MeSH NLM).

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )